Smith & Nephew PLC has announced the efficiency of its GRAFIX Membrane which reduces diabetic foot ulcer recurrence by half as compared to other leading competitors.
Integra LifeSciences Corporation announced the positive clinical outcomes with its PriMatrix Dermal Repair Scaffold for the treatment of hard-to-heal diabetic foot ulcers (DFUs). This is the largest DFU RCT ever conducted. A per protocol analysis found that 60% of DFUs healed within 12 weeks when PriMatrix was used in conjunction with standard care (SOC), compared to 35% for DFUs that healed within 12 weeks when SOC was used.
Author Credits: Radhika Gupta, Shivam Bhutani